These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25011204)

  • 21. New oral anticoagulants after acute coronary syndrome.
    Bennaghmouch N; Ten Berg JM
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):141-50. PubMed ID: 23953902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery.
    Harenberg J; Marx S; Dahl OE; Marder VJ; Schulze A; Wehling M; Weiss C
    Thromb Haemost; 2012 Nov; 108(5):903-12. PubMed ID: 23014668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
    Gong IY; Kim RB
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S24-33. PubMed ID: 23790595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expanded arsenal in atrial fibrillation: bye-bye marcumar?].
    MMW Fortschr Med; 2012 Jan; 154(1):20. PubMed ID: 22641998
    [No Abstract]   [Full Text] [Related]  

  • 25. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
    Lenchus JD
    Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS; Lip GY
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].
    Szapary L; Fehér G; Bosnyák E; Deli G; Csécsei P
    Ideggyogy Sz; 2013 May; 66(5-6):165-74. PubMed ID: 23909016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The promise of pharmacoepidemiology in helping clinicians assess drug risk.
    Avorn J
    Circulation; 2013 Aug; 128(7):745-8. PubMed ID: 23940388
    [No Abstract]   [Full Text] [Related]  

  • 30. [General characteristics of the new oral anticoagulants].
    Gegu M; Chevalet P; Piloquet FX; Berrut G; De Decker L
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):4-9. PubMed ID: 24463058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants.
    Miller MP; Trujillo TC; Nordenholz KE
    Am J Emerg Med; 2014 Apr; 32(4):375-82. PubMed ID: 24512886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.
    Brem E; Koyfman A; Foran M
    J Emerg Med; 2013 Jul; 45(1):143-9. PubMed ID: 23375217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transitions of care in anticoagulation management for patients with atrial fibrillation.
    Deitelzweig SB
    Hosp Pract (1995); 2012 Oct; 40(4):20-7. PubMed ID: 23299032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral hemorrhage under rivaroxaban.
    Stöllberger C; Zuntner G; Bastovansky A; Finsterer J
    Int J Cardiol; 2013 Sep; 167(6):e179-81. PubMed ID: 23651821
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation.
    Testa L; Agnifili M; Latini RA; Mattioli R; Lanotte S; De Marco F; Oreglia J; Latib A; Pizzocri S; Laudisa ML; Brambilla N; Bedogni F
    QJM; 2012 Oct; 105(10):949-57. PubMed ID: 22771555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
    Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel oral anticoagulants in gastroenterology practice.
    Desai J; Granger CB; Weitz JI; Aisenberg J
    Gastrointest Endosc; 2013 Aug; 78(2):227-39. PubMed ID: 23725876
    [No Abstract]   [Full Text] [Related]  

  • 40. The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out.
    Kowey PR; Naccarelli GV
    Am J Med; 2012 Aug; 125(8):732. PubMed ID: 22608987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.